![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1359313 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UTP14A mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of UTP14A mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | decreases expression | ISO | RGD:1552134 | 6480464 | ethylene dichloride results in decreased expression of UTP14A mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1552134 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UTP14A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1552134 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UTP14A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1359313 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UTP14A mRNA | CTD | PMID:21215274, PMID:32109520 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1359313 | 6480464 | 2, 6-dinitrotoluene affects the expression of UTP14A mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of UTP14A mRNA | CTD | PMID:21179406 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | RGD:1359313 | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of UTP14A mRNA | CTD | PMID:21346803 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of UTP14A mRNA | CTD | PMID:24449571 | benzo[a]pyrene | multiple interactions | ISO | RGD:1552134 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of UTP14A promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of UTP14A exon | CTD | PMID:27901495 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1552134 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA | CTD | PMID:27858113 | bisphenol A | increases expression | ISO | RGD:1552134 | 6480464 | bisphenol A results in increased expression of UTP14A mRNA | CTD | PMID:25594700, PMID:26063408 | bisphenol A | decreases expression | ISO | RGD:1359313 | 6480464 | bisphenol A results in decreased expression of UTP14A mRNA | CTD | PMID:30816183 | bisphenol A | increases expression | ISO | RGD:1359313 | 6480464 | bisphenol A results in increased expression of UTP14A mRNA | CTD | PMID:25181051 | chrysene | multiple interactions | ISO | RGD:1552134 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA | CTD | PMID:27858113 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of UTP14A mRNA | CTD | PMID:27392435 | clobetasol | decreases expression | ISO | RGD:1552134 | 6480464 | Clobetasol results in decreased expression of UTP14A mRNA | CTD | PMID:27462272 | curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of UTP14A mRNA | CTD | PMID:17198877 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of UTP14A mRNA | CTD | PMID:20106945, PMID:25562108 | diazinon | decreases methylation | EXP | | 6480464 | Diazinon results in decreased methylation of UTP14A gene | CTD | PMID:22964155 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of UTP14A mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | RGD:1552134 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP14A mRNA | CTD | PMID:30529165 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of UTP14A mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UTP14A protein | CTD | PMID:23301498 | flutamide | increases expression | ISO | RGD:1359313 | 6480464 | Flutamide results in increased expression of UTP14A mRNA | CTD | PMID:24136188 | flutamide | decreases expression | ISO | RGD:1359313 | 6480464 | Flutamide results in decreased expression of UTP14A mRNA | CTD | PMID:24793618 | folic acid | decreases expression | ISO | RGD:1552134 | 6480464 | Folic Acid results in decreased expression of UTP14A mRNA | CTD | PMID:25629700 | hexadecanoic acid | decreases phosphorylation | EXP | | 6480464 | Palmitic Acid results in decreased phosphorylation of UTP14A protein | CTD | PMID:28073184 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of UTP14A mRNA | CTD | PMID:25583101 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of UTP14A mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromateVI results in increased expression of UTP14A mRNA | CTD | PMID:22079256 | rotenone | increases expression | ISO | RGD:1359313 | 6480464 | Rotenone results in increased expression of UTP14A mRNA | CTD | PMID:28374803 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of UTP14A mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of UTP14A mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | ISO | RGD:1359313 | 6480464 | Carbon Tetrachloride results in increased expression of UTP14A mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:1359313 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UTP14A mRNA] | CTD | PMID:31150632 | tetraphene | decreases expression | ISO | RGD:1552134 | 6480464 | benzaanthracene results in decreased expression of UTP14A mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | RGD:1552134 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA | CTD | PMID:27858113 | tungsten | decreases expression | ISO | RGD:1552134 | 6480464 | Tungsten results in decreased expression of UTP14A mRNA | CTD | PMID:30912803 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of UTP14A mRNA | CTD | PMID:23179753 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of UTP14A mRNA | CTD | PMID:25979313 | |